Monte Carlo calculations of dose distributions around 32P and 198Au stents for intravascular brachytherapy

Medical Physics

Volumn 26, Issue 8, 1999, Pages 1484-1491

  Reynaert, N ^a   Verhaegen, F ^a   Taeymans, Y ^b   Van Eijkeren, M ^b   Thierens, H ^a  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Intravascular brachytherapy; Monte Carlo calculations; Stents

Indexed keywords

MONTE CARLO METHODS; ONCOLOGY; RADIOTHERAPY; STRUTS;

CLINICAL PRACTICES; DOSE DISTRIBUTIONS; EGS4 MONTE CARLO SIMULATION; INHOMOGENEITIES; INTRAVASCULAR BRACHYTHERAPY; MONTE CARLO CALCULATION; MONTE CARLO CODES; PEAK-TO-VALLEY RATIOS;

STENTS;

GOLD 198; PHOSPHORUS 32;

ARTICLE; BRACHYTHERAPY; DOSIMETRY; ELECTRON TRANSPORT; PRIORITY JOURNAL; RADIATION ABSORPTION; RADIATION DOSE DISTRIBUTION; STENT; SYSTEM ANALYSIS;

EID: 0032803558     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.598644     Document Type: Article

References (26)

1. 192Ir endovascular brachytherapy for avoidance of intimal hyperplasia after percutaneous transluminal angioplasty and stent implantation in peripheral vessels: 6 years of experience," Int. J. Radiat. Oncol., Biol., Phys. 36, 835-840 (1996).
2. C. Janicki, D. M. Duggan, C. W. Coffey, D. R. Fischell, and T. A. Fischell, "Radiation from a phosphorous-32 impregnated wire mesh vascular stent," Med. Phys. 24, 437-445 (1997).
3. T. A. Fischell, B. K. Kharma, D. R. Fischell, P. G. Loges, C. W. Coffey, D. M. Duggan, and A. J. Naftilan, "Low-dose ß-particle emission from 'stent' wire results in complete, localized inhibition of smooth muscle cell proliferation," Circulation 90, 2956-2963 (1994).
4. Y. Shi, J. E. O'Brien, L. Ala-Kokko, W. Chung, J. D. Mannion, and A. Zalewski, "Origin of extracellular matrix synthesis during coronary repair," Circulation 95, 997-1006 (1997).
5. R. Waksman, J. C. Rodriguez, K. A. Robinson, G. D. Cipolla, I. R. Crocker, N. A. Scott, S. B. King, and J. N. Wilcox, "Effect of intravascular irradiation on cell proliferation, apoptosis, and vascular remodeling after balloon overstretch injury of porcine coronary arteries," Circulation 96, 1944-1952 (1997).
6. W. J. van der Giessen and P. W. Serruys, "ß-particle-emitting stents radiate enthusiasm in the search for effective prevention of restenosis," Circulation 94, 2358-2360 (1996).
7. A. N. Li, N. L. Eigler, F. Litvack, and J. S. Whiting, "Characterization of a positron emitting V48 nitinol stent for intracoronary brachytherapy," Med. Phys. 25, 20-28 (1998).
8. 32P-impregnated coronary stent: Comparison of theoretical calculations and measurements with radiochromic film," Int. J. Radiat. Oncol., Biol., Phys. 40, 713-720 (1998).
9. D. Nori, S. Parikh, and J. Moni, "Management of pheripheral vascular disease: Innovative approaches using radiation therapy," Int. J. Radiat. Oncol., Biol., Phys. 36, 847-856 (1996).
10. H. B. Wolkov and M. Bagshaw, "Conventional radiation therapy in the management of arteriovenous malformations of the central nervous system," Int. J. Radiat. Oncol., Biol., Phys. 15, 1461-1464 (1988).
11. R. Waksman, K. A. Robinson, I. R. Crocker, C. Wang, M. B. Gravanis, G. D. Cipolla, R. A. Hillstead, and S. B. King, "Intracoronary low-dose ß-irradiation inhibits neointima formation after coronary artery balloon injury in the swine restenosis model," Circulation 92, 3025-3031 (1995).
12. P. S. Teirstein, V. Massullo, S. Jani, J. J. Popma, G. S. Mintz, R. J. Russo, R. A. Schatz, E. M. Guarneri, S. Steuterman, N. B. Morris, M. B. Leon, and P. Tripuraneni, "Catheter-based radiotherapy to inhibit restenosis after coronary stenting," N. Engl. J. Med. 336, 1697-1703 (1997).
13. 32P-coated stent," Med. Phys. 22, 313-320 (1995).
14. 32P source for endovascular irradiation," Int. J. Radiat. Oncol., Biol., Phys. 36, 933-939 (1996).
15. R. Loevinger, E. M. Japha, and G. L. Brownell, "Discrete radioisotope sources" in Radiation Dosimetry, edited by H. J. Hine and G. L. Brownell (Academic, New York, 1956), pp. 693-799.
16. H. I. Amols, M. Zaider, J. Weinberger, R. Ennis, P. B. Schiff, and L. E. Reinstein, "Dosimetric considerations for catheter-based beta and gamma emitters in the therapy of neointimal hyperplasia in human coronary arteries," Int. J. Radiat. Oncol., Biol., Phys. 36, 913-921 (1996).
17. W. V. Prestwich, J. Nunes, and C. S. Kwok, "Beta dose point kernels for radionuclides of potential use in radioimmunotherapy, " J. Nucl. Med. 30, 1036-1046 (1989).
18. MCNP-A General Monte Carlo N-Particle Transport Code (computer program), Briesmeister JF. Version 4A, Radiation Shielding Information Center, Los Alamos, New Mexico, 1993, LA-12625-M.
19. W. R. Nelson, H. Hirayama, and D. W. O. Rogers, "The EGS4 code system," Stanford Linear Accelerator Report No. SLAC-265.
20. A. Bielajew and I. Kawrakov, "High accuracy Monte Carlo calculations, Abstract on the World Congress on Medical Physics and Biomedical Engineering, Nice, September 14-19, 1997, p. 1096.
21. V. S. Shirley, Nucl. Data Sheets 64, 205 (1991).
22. L. L. Anderson, R. Nath, K. A. Weaver, D. Nori, T. L. Phillips, Y. H. Son, S-T. Chiu Tsao, A. S. Meigooni, J. A. Meli, and V. Smith, Interstitial Collaborative Working Group, Interstitial Brachytherapy, Physical, Biological, and Clinical Considerations (Raven, New York, 1990).
23. R. Nath, L. Anderson, G. Luxton, K. Weaver, J. F. Williamson, and A. S. Meigooni, "Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group 43," Med. Phys. 22, 209-234 (1991).
24. 192Ir sources," Med. Phys. 22, 809-819 (1995).
25. A. J. Carter and T. A. Fischell, "Current status of radioactive stents for the prevention of instent restenosis," Int. J. Radiat. Oncol., Biol., Phys. 41, 127-133 (1998).
26. C. Hehrlein, M. Stintz, R. Kinscherf, K. Schlösser, E. Huttel, L. Friedrich, P. Fehsenfeld, and W. Kübier, "Pure ß-particle-emitting stents inhibit neointima formation in rabbits," Circulation 93, 641-645 (1996).